These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16525564)

  • 21. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 22. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between regular aerobic physical exercise and inflammatory markers.
    Lippi G; Bassi A; Guidi G; Zatti M
    Am J Cardiol; 2002 Oct; 90(7):820. PubMed ID: 12356414
    [No Abstract]   [Full Text] [Related]  

  • 25. [The importance of non-lipid risk factors: a review focusing on C-reactive protein].
    Yilmaz Y; Ongen Z
    Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():7-13. PubMed ID: 19553756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory biomarkers in coronary artery disease.
    Zakynthinos E; Pappa N
    J Cardiol; 2009 Jun; 53(3):317-33. PubMed ID: 19477372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on cardiovascular disease risk factors in menorrhagia patients: a 10-year follow-up of a randomised trial.
    Heliövaara-Peippo S; Oksjoki R; Halmesmäki K; Kaaja R; Teperi J; Grenman S; Kivelä A; Surcel HM; Tomas E; Tuppurainen M; Hurskainen R; Paavonen J
    Maturitas; 2011 Aug; 69(4):354-8. PubMed ID: 21684096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory markers in coronary artery disease.
    Ikonomidis I; Michalakeas CA; Parissis J; Paraskevaidis I; Ntai K; Papadakis I; Anastasiou-Nana M; Lekakis J
    Biofactors; 2012; 38(5):320-8. PubMed ID: 22628054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein: a novel marker of cardiovascular risk.
    Shah SH; Newby LK
    Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Markers of inflammatory process in stable and unstable coronary artery disease].
    Okopień B; Basiak M; Madej A; Labuzek K; Belowski D; Haberka M; Herman ZS
    Pol Merkur Lekarski; 2006 Jul; 21(121):69-72. PubMed ID: 17007298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey.
    Bakhru A; Erlinger TP
    PLoS Med; 2005 Jun; 2(6):e160. PubMed ID: 15974805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective.
    Wilson PW
    Am J Med; 2008 Oct; 121(10 Suppl 1):S15-20. PubMed ID: 18926165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA Study.
    Panagiotakos DB; Pitsavos C; Chrysohoou C; Kavouras S; Stefanadis C;
    Prev Med; 2005 Apr; 40(4):432-7. PubMed ID: 15530595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-hypertension: Is it an inflammatory state?
    Nandeesha H; Bobby Z; Selvaraj N; Rajappa M
    Clin Chim Acta; 2015 Dec; 451(Pt B):338-42. PubMed ID: 26525963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipids and primary prevention of coronary disease].
    Idzior-Waluś B
    Przegl Lek; 1998; 55(2):77-84. PubMed ID: 9695648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study.
    Cesari M; Penninx BW; Newman AB; Kritchevsky SB; Nicklas BJ; Sutton-Tyrrell K; Rubin SM; Ding J; Simonsick EM; Harris TB; Pahor M
    Circulation; 2003 Nov; 108(19):2317-22. PubMed ID: 14568895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice.
    Avan A; Tavakoly Sany SB; Ghayour-Mobarhan M; Rahimi HR; Tajfard M; Ferns G
    J Cell Physiol; 2018 Nov; 233(11):8508-8525. PubMed ID: 29932219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with hypertension and the cardiometabolic syndrome: the potential impact of inflammatory biomarkers.
    Morris A; Ferdinand KC
    J Clin Hypertens (Greenwich); 2009 Nov; 11(11):690-3. PubMed ID: 19878385
    [No Abstract]   [Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.